FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012414280> ?p ?o ?g. }

• W2012414280 abstract "Coinfection with the hepatitis viruses is common in the HIV population in sub-Saharan Africa. The aim of this study was to assess, in a cohort of HIV-infected pregnant women receiving antiretroviral drugs (ARVs), the prevalence of HBV and HCV infections and to determine the impact of these infections on the occurrence of liver toxicity and on the viro-immunological response.Women were screened for HBsAg and HCV-RNA before starting, at week 25 of gestational age, an antiretroviral regimen consisting of lamivudine and nevirapine plus either stavudine or zidovudine. Women with CD4+ < 350/mm3 continued ARVs indefinitely, while the other women interrupted treatment 6 months postpartum (end of breastfeeding period). Both groups were followed for 2 years after delivery. Liver function was monitored by alanine aminotransferase (ALT) measurement. The Cox proportional hazards model was used to identify factors associated with the emergence of liver toxicity.A total of 28 women out of the 309 enrolled in the study (9.1%) were coinfected with HBV (n. 27), or HCV (n. 1). During follow-up 125 women (40.4%) developed a grade ≥ 1 ALT elevation, 28 (9.1%) a grade ≥ 2 and 6 (1.9%) an elevation defining grade 3 toxicity. In a multivariate model including age, baseline CD4+ count and hemoglobin level, the presence of either HBV or HCV infection was significantly associated with the development of an ALT increase of any grade (P = 0.035). Moderate or severe liver laboratory toxicity (grade ≥ 2) was more frequent among women with baseline CD4+ > 250/mm3 (P = 0.030). In HBV-infected women a baseline HBV-DNA level above 10,000 IU/ml was significantly associated to the development of liver toxicity of grade ≥ 1 (P = 0.040). Coinfections had no impact on the immunological and virological response to antiretroviral drugs up to 2 years after delivery.In this cohort of nevirapine-treated women the presence of HBV or HCV was associated only to the development of mild liver toxicity, while the occurrence of moderate or severe hepatoxicity was correlated to a baseline CD4+ count > 250/mm3. No statistically significant effect of the coinfections was observed on the efficacy of antiretroviral therapy." @default.
• W2012414280 created "2016-06-24" @default.
• W2012414280 creator A5004452975 @default.
• W2012414280 creator A5029614277 @default.
• W2012414280 creator A5034255777 @default.
• W2012414280 creator A5034403948 @default.
• W2012414280 creator A5034750163 @default.
• W2012414280 creator A5036142555 @default.
• W2012414280 creator A5039179221 @default.
• W2012414280 creator A5044583429 @default.
• W2012414280 creator A5047777094 @default.
• W2012414280 creator A5048907372 @default.
• W2012414280 creator A5049170322 @default.
• W2012414280 creator A5063101480 @default.
• W2012414280 creator A5067274753 @default.
• W2012414280 creator A5073685064 @default.
• W2012414280 creator A5074899735 @default.
• W2012414280 date "2014-04-04" @default.
• W2012414280 modified "2023-10-07" @default.
• W2012414280 title "The impact of HBV or HCV infection in a cohort of HIV-infected pregnant women receiving a nevirapine-based antiretroviral regimen in Malawi" @default.
• W2012414280 cites W1946305991 @default.
• W2012414280 cites W1984711089 @default.
• W2012414280 cites W1988633607 @default.
• W2012414280 cites W1996065655 @default.
• W2012414280 cites W2001006901 @default.
• W2012414280 cites W2005727382 @default.
• W2012414280 cites W2015959530 @default.
• W2012414280 cites W2018798881 @default.
• W2012414280 cites W2025264494 @default.
• W2012414280 cites W2045682237 @default.
• W2012414280 cites W2070895726 @default.
• W2012414280 cites W2097504774 @default.
• W2012414280 cites W2099306766 @default.
• W2012414280 cites W2118551595 @default.
• W2012414280 cites W2126949656 @default.
• W2012414280 cites W2148154755 @default.
• W2012414280 cites W2169574907 @default.
• W2012414280 doi "https://doi.org/10.1186/1471-2334-14-180" @default.
• W2012414280 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4234206" @default.
• W2012414280 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24708626" @default.
• W2012414280 hasPublicationYear "2014" @default.
• W2012414280 type Work @default.
• W2012414280 sameAs 2012414280 @default.
• W2012414280 citedByCount "12" @default.
• W2012414280 countsByYear W20124142802015 @default.
• W2012414280 countsByYear W20124142802016 @default.
• W2012414280 countsByYear W20124142802017 @default.
• W2012414280 countsByYear W20124142802018 @default.
• W2012414280 countsByYear W20124142802019 @default.
• W2012414280 countsByYear W20124142802020 @default.
• W2012414280 countsByYear W20124142802022 @default.
• W2012414280 countsByYear W20124142802023 @default.
• W2012414280 crossrefType "journal-article" @default.
• W2012414280 hasAuthorship W2012414280A5004452975 @default.
• W2012414280 hasAuthorship W2012414280A5029614277 @default.
• W2012414280 hasAuthorship W2012414280A5034255777 @default.
• W2012414280 hasAuthorship W2012414280A5034403948 @default.
• W2012414280 hasAuthorship W2012414280A5034750163 @default.
• W2012414280 hasAuthorship W2012414280A5036142555 @default.
• W2012414280 hasAuthorship W2012414280A5039179221 @default.
• W2012414280 hasAuthorship W2012414280A5044583429 @default.
• W2012414280 hasAuthorship W2012414280A5047777094 @default.
• W2012414280 hasAuthorship W2012414280A5048907372 @default.
• W2012414280 hasAuthorship W2012414280A5049170322 @default.
• W2012414280 hasAuthorship W2012414280A5063101480 @default.
• W2012414280 hasAuthorship W2012414280A5067274753 @default.
• W2012414280 hasAuthorship W2012414280A5073685064 @default.
• W2012414280 hasAuthorship W2012414280A5074899735 @default.
• W2012414280 hasBestOaLocation W20124142801 @default.
• W2012414280 hasConcept C126322002 @default.
• W2012414280 hasConcept C142462285 @default.
• W2012414280 hasConcept C203014093 @default.
• W2012414280 hasConcept C2522874641 @default.
• W2012414280 hasConcept C2776455275 @default.
• W2012414280 hasConcept C2777410769 @default.
• W2012414280 hasConcept C2777813720 @default.
• W2012414280 hasConcept C2777869810 @default.
• W2012414280 hasConcept C2779130552 @default.
• W2012414280 hasConcept C2780216070 @default.
• W2012414280 hasConcept C2780593183 @default.
• W2012414280 hasConcept C2780727368 @default.
• W2012414280 hasConcept C2781413609 @default.
• W2012414280 hasConcept C2908647359 @default.
• W2012414280 hasConcept C2992208098 @default.
• W2012414280 hasConcept C2993143319 @default.
• W2012414280 hasConcept C3013748606 @default.
• W2012414280 hasConcept C71924100 @default.
• W2012414280 hasConcept C72563966 @default.
• W2012414280 hasConcept C99454951 @default.
• W2012414280 hasConceptScore W2012414280C126322002 @default.
• W2012414280 hasConceptScore W2012414280C142462285 @default.
• W2012414280 hasConceptScore W2012414280C203014093 @default.
• W2012414280 hasConceptScore W2012414280C2522874641 @default.
• W2012414280 hasConceptScore W2012414280C2776455275 @default.
• W2012414280 hasConceptScore W2012414280C2777410769 @default.
• W2012414280 hasConceptScore W2012414280C2777813720 @default.
• W2012414280 hasConceptScore W2012414280C2777869810 @default.
• W2012414280 hasConceptScore W2012414280C2779130552 @default.
• W2012414280 hasConceptScore W2012414280C2780216070 @default.
• W2012414280 hasConceptScore W2012414280C2780593183 @default.

• next